Form 4 holding
Director
RECURSION PHARMACEUTICALS, INC.
- Security class
- Class A Common Stock
- Shares / value
- 71,254
- Estimated value
- $514,098
- Report date
- 01 Jul 2024
- Price
- $7.22
- Ownership
- Direct
Terry-Ann Burrell - Director at RECURSION PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- RXRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Terry-Ann Burrell since 13 Sep 2025
Reported holdings for Terry-Ann Burrell in RECURSION PHARMACEUTICALS, INC.
Form 4 holding
Director
RECURSION PHARMACEUTICALS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 26,193
- Estimated value
- Report date
- 03 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
Transaction history for Terry-Ann Burrell in RECURSION PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.